Welcome to our dedicated page for Siriuspoint news (Ticker: SPNT), a resource for investors and traders seeking the latest updates and insights on Siriuspoint stock.
SiriusPoint Ltd. reports news as a Bermuda-headquartered specialty underwriter of insurance and reinsurance listed on the NYSE under SPNT. Company updates center on underwriting results, written premium trends, combined ratios, book value, capital returns, and financial strength ratings for its operating subsidiaries.
SiriusPoint’s recurring developments also cover its global Property & Casualty and Accident & Health insurance and reinsurance licenses, strategic partnerships with Managing General Agents and Program Administrators, and its operating structure across Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty, including Lloyd’s. Governance updates include board composition, committee roles, and executive or organizational changes tied to its underwriting platforms.
SiriusPoint (NYSE: SPNT) announced that Will Nihan will become Chief Executive Officer of International Medical Group (IMG), its wholly owned subsidiary, effective 3 November 2025. Nihan joins from Travelex Insurance Services, where he served as President and CEO and is credited with driving top-line growth and improved profitability. His prior roles include North America Head of Sales and Distribution at Zurich Global Ventures and senior marketing roles at Prudential and AIG. Nihan replaces Adam Hirschfeld, who served as Interim CEO since March 2025 and will remain on IMG’s executive team to support the transition and IMG’s growth and transformation.
SiriusPoint (NYSE: SPNT) will release its third quarter 2025 financial results after market close on Thursday, October 30, 2025. The company will host a conference call with Q&A at 8:30 AM ET on Friday, October 31, 2025. Investors can access a live webcast via the Investor Relations section at www.siriuspt.com and an online replay immediately after the call.
Telephone access: 1-877-451-6152 (U.S.) or 1-201-389-0879 (international). Replay available until 11:59 PM ET on November 14, 2025 via dial-in with passcode 13755914.
SiriusPoint (NYSE: SPNT) announced on Oct 6, 2025 the sale of its 49% equity stake in Arcadian MGA to Lee Equity Partners for $139 million (inclusive of a pre-close dividend). The company said it will recognize a $25–30 million pre-tax gain on completion, in addition to a $96 million gain recorded in Q2 2024. The press release states SiriusPoint renewed and extended its capacity agreement with Arcadian through end-2031. Arcadian reported $17.6 million EBITDA (per the PR). Closing is expected before Q1 2026, subject to regulatory approvals and customary conditions.
SiriusPoint (NYSE:SPNT) received a significant boost as S&P Global Ratings revised its outlook to Positive from Stable, while affirming the company's 'A-' issuer credit and financial strength ratings for core operating subsidiaries and 'BBB' long-term issuer credit rating.
The improved outlook stems from SiriusPoint's strong underwriting profits over the past 2.5 years and significantly reduced risk profile, particularly in natural catastrophe and investment exposure. Notably, all three major rating agencies - S&P, Fitch, and AM Best - have now revised SiriusPoint's outlook to Positive in 2025, highlighting the company's successful strategy in risk reduction, underwriting excellence, and disciplined investment approach.
Ambac Financial Group (NYSE: AMBC) has announced the acquisition of ArmadaCare from SiriusPoint for $250 million. ArmadaCare, headquartered in Hunt Valley, Maryland, is a leading supplemental health insurance program manager specializing in innovative workplace benefit products.
The transaction will be financed through a combination of cash and new debt, including a $120 million commitment from Truist Bank. The deal is expected to close in Q4 2025 and become accretive to shareholders by 2026. ArmadaCare's current CEO Ed Walker will continue leading the health insurance business with his management team.
This strategic acquisition follows Ambac's transformation into a pure-play MGA and specialty insurance platform, strengthening its market position and accelerating its specialty insurance distribution strategy.
SiriusPoint (NYSE: SPNT) has agreed to sell ArmadaCare, its supplemental health insurance program manager, to Ambac Financial Group for $250 million. The transaction values Armada at approximately 14x EBITDA and is expected to generate a pre-tax gain of $220-230 million for SiriusPoint.
While divesting its equity stake, SiriusPoint will maintain a capacity partnership with Armada through 2030. The deal is anticipated to increase pro-forma tangible book value by 10% upon closing in Q4 2025. The company maintains its across-the-cycle target return on equity of 12% to 15% and continues to see growth opportunities in its Accident & Health segment, including through its International Medical Group platform.
SiriusPoint (NYSE:SPNT), a global specialty insurer and reinsurer, has appointed Martin Hudson as Board Director, effective September 1, 2025. Hudson brings over 40 years of international (re)insurance leadership experience in underwriting, risk management, governance, and executive management.
Hudson currently serves as Independent Non-Executive Director at Liberty Mutual Managing Agency Ltd and Liberty Mutual Insurance Europe SE. His extensive career includes senior executive positions at Travelers Insurance, Mitsui Sumitomo Insurance Group, and Old Mutual Specialty Insurance, with experience spanning the US, UK, Europe, Canada, and Asia.
SiriusPoint (NYSE:SPNT) reported strong Q2 2025 results with significant improvements in key metrics. The company achieved a Core combined ratio of 89.5%, representing a 3.8-point improvement from the previous year. Underwriting income grew 83% year-over-year to $68 million for Core business.
Key financial highlights include net income of $59.2 million ($0.50 per diluted share), Core income of $76.3 million, and gross premiums written growth of 10% marking the fifth consecutive quarter of double-digit growth. The company's return on equity reached 12.7%, with underlying ROE of 17.0% exceeding their 12-15% target range.
Book value per diluted common share (ex. AOCI) increased by 3.2% to $15.64, and the company maintained a strong balance sheet with a Q2'25 BSCR estimate at 223%. The Insurance & Services segment showed particularly strong performance with a 14.3% increase in gross premiums written to $560.4 million.
SiriusPoint (NYSE:SPNT), an international specialty insurer and reinsurer, has declared a quarterly cash dividend for its Series B Preference Shares. The company will pay $0.50 per share on its 8.00% Resettable Fixed Rate Preference Shares, Series B, which have a $0.10 par value and $25.00 liquidation preference per share.
The dividend will be paid on or before August 29, 2025 to Series B shareholders of record as of August 14, 2025.
SiriusPoint (NYSE:SPNT) has scheduled its second quarter 2025 earnings release for Monday, August 4, 2025, before market open. The company will host a conference call with a Q&A session at 8:30 a.m. Eastern Time on the same day.
Investors can access the live webcast through the Investor Relations section of SiriusPoint's website. For those preferring phone access, the call can be joined via 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available until August 18, 2025, accessible through the website or by phone using passcode 13754248.